These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7097538)

  • 21. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
    Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
    Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
    Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective glucuronidation of formoterol by human liver microsomes.
    Zhang M; Fawcett JP; Kennedy JM; Shaw JP
    Br J Clin Pharmacol; 2000 Feb; 49(2):152-7. PubMed ID: 10671910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective metabolic disposition of enantiomers of ofloxacin in rats.
    Okazaki O; Kurata T; Tachizawa H
    Xenobiotica; 1989 Apr; 19(4):419-29. PubMed ID: 2501940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
    Walle T; Wilson MJ; Walle UK; Bai SA
    Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein.
    Volland C; Sun H; Dammeyer J; Benet LZ
    Drug Metab Dispos; 1991; 19(6):1080-6. PubMed ID: 1687014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective steady state disposition and action of propafenone in Chinese subjects.
    Li G; Gong PL; Qiu J; Zeng FD; Klotz U
    Br J Clin Pharmacol; 1998 Nov; 46(5):441-5. PubMed ID: 9833596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.
    Haegele KD; Schechter PJ
    Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers.
    Wong SL; Awni WM; Cavanaugh JH; el-Shourbagy T; Locke CS; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():9-21. PubMed ID: 8620676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age and gender influence the stereoselective pharmacokinetics of propranolol.
    Gilmore DA; Gal J; Gerber JG; Nies AS
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantiomeric activation of glucuronidation in dog hepatic microsomes.
    Sweeny DJ; Nellans HN
    J Biol Chem; 1992 Jul; 267(19):13171-4. PubMed ID: 1618819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
    Egginger G; Lindner W; Brunner G; Stoschitzky K
    J Pharm Biomed Anal; 1994 Dec; 12(12):1537-45. PubMed ID: 7696378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.
    Grubb NG; Rudy DW; Brater DC; Hall SD
    Br J Clin Pharmacol; 1999 Oct; 48(4):494-500. PubMed ID: 10583018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
    Dahl-Puustinen ML; Perry TL; Dumont E; von Bahr C; Nordin C; Bertilsson L
    Clin Pharmacol Ther; 1989 Jun; 45(6):650-6. PubMed ID: 2731406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
    Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
    Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of age on the protein binding and disposition of propranolol stereoisomers.
    Lalonde RL; Tenero DM; Burlew BS; Herring VL; Bottorff MB
    Clin Pharmacol Ther; 1990 Apr; 47(4):447-55. PubMed ID: 2328552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits.
    Nomura T; Imai T; Otagiri M
    Biol Pharm Bull; 1993 Mar; 16(3):298-303. PubMed ID: 8364476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of the enantiomers of mexiletine in humans.
    Igwemezie L; Kerr CR; McErlane KM
    Xenobiotica; 1989 Jun; 19(6):677-82. PubMed ID: 2763576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranolol.
    Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE
    Clin Pharmacol Ther; 1979 Dec; 26(6):686-95. PubMed ID: 498710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.